Other data have demonstrated that the loss of Arid1a enhances NAFLD by downregulating PPARα, thereby blocking fatty acid oxidation and leading to lipogenesis and insulin resistance [29,30]. Here, ARID1A is linked to metabolic dysfunction-associated steatotic liver disease.